An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers in the Institute ...
Jan 29, 2022
0
276
US biotech company Moderna said Thursday it had mixed results from a large-scale trial of its mRNA flu shot, based on the same technology used in its successful Covid-19 vaccine.
Feb 17, 2023
0
66
A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences ...
Jul 8, 2022
0
366
Researchers at McMaster University have found that children who receive years of season-specific flu vaccines develop antibodies that also provide broader protection against new strains, including those capable of causing ...
Feb 3, 2022
0
256
When most of us get the flu, we spend three or four days on the couch feeling miserable, then we bounce back pretty quickly. But others have more severe symptoms and need to be hospitalised because they're at risk of life-threatening ...
Apr 15, 2019
0
1
(Edmonton) A University of Alberta engineering researcher has developed a new way to treat common surgical masks so they are capable of trapping and killing airborne viruses. His research findings appear in the prestigious ...
Jan 5, 2017
0
684
In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.
Aug 4, 2021
0
503
Development of a universal flu vaccine has been a long-sought goal, and as flu scientists begin to see light at the end of a decades-long tunnel, encouraging data have emerged on an experimental shot. It appears effective ...
US biotech firm Moderna said Wednesday it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza.
Jul 7, 2021
0
777
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295
